Home › Selecting comparators for drugs with multiple indications and complex treatment patterns: Example with daratumumab in multiple myeloma

Selecting comparators for drugs with multiple indications and complex treatment patterns: Example with daratumumab in multiple myeloma

Laura L. Hester, PhD, Dina Gifkins, PhD, Patrick B. Ryan, PhD

1 Janssen Research and Development, LLC, Titusville, NJ

Files

Poster PDF
Abstract
Additional Information